ciclopirox has been researched along with Chronic Hepatitis B in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, JA | 1 |
| Kim, S | 1 |
| Park, M | 1 |
| Park, HJ | 1 |
| Kim, JH | 1 |
| Park, S | 1 |
| Hwang, JR | 1 |
| Kim, YC | 1 |
| Jun Kim, Y | 1 |
| Cho, Y | 1 |
| Sun Jin, M | 1 |
| Park, SG | 1 |
1 other study available for ciclopirox and Chronic Hepatitis B
| Article | Year |
|---|---|
Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assembly.
Topics: Animals; Antiviral Agents; Capsid; Ciclopirox; Crystallography, X-Ray; Disease Models, Animal; Drug | 2019 |